Association of asthma symptoms with peak particulate air pollution and effect modification by anti-inflammatory medication use.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMC 1241047)

Published in Environ Health Perspect on October 01, 2002

Authors

Ralph J Delfino1, Robert S Zeiger, James M Seltzer, Donald H Street, Christine E McLaren

Author Affiliations

1: Epidemiology Division, Department of Medicine, University of California, Irvine, Irvine, California 92697-7550, USA. rdelfino@uci.edu

Articles citing this

Community-based participatory research: lessons learned from the Centers for Children's Environmental Health and Disease Prevention Research. Environ Health Perspect (2005) 5.40

Diabetes, obesity, and hypertension may enhance associations between air pollution and markers of systemic inflammation. Environ Health Perspect (2006) 3.23

Association of FEV1 in asthmatic children with personal and microenvironmental exposure to airborne particulate matter. Environ Health Perspect (2004) 2.34

Pulmonary effects of indoor- and outdoor-generated particles in children with asthma. Environ Health Perspect (2005) 2.01

Personal and ambient air pollution is associated with increased exhaled nitric oxide in children with asthma. Environ Health Perspect (2006) 1.70

Outdoor air pollution and asthma. Lancet (2014) 1.64

Asthma symptoms in Hispanic children and daily ambient exposures to toxic and criteria air pollutants. Environ Health Perspect (2003) 1.64

Short-term effects of PM10 and NO2 on respiratory health among children with asthma or asthma-like symptoms: a systematic review and meta-analysis. Environ Health Perspect (2009) 1.54

Measurement of offline exhaled nitric oxide in a study of community exposure to air pollution. Environ Health Perspect (2003) 1.46

Air pollution-associated changes in lung function among asthmatic children in Detroit. Environ Health Perspect (2005) 1.45

Personal and ambient air pollution exposures and lung function decrements in children with asthma. Environ Health Perspect (2008) 1.32

Tracking pediatric asthma: the Massachusetts experience using school health records. Environ Health Perspect (2004) 1.29

Air concentrations of volatile compounds near oil and gas production: a community-based exploratory study. Environ Health (2014) 1.24

A systematic review of the physical health impacts from non-occupational exposure to wildfire smoke. Environ Res (2014) 1.22

Indoor environmental exposures and exacerbation of asthma: an update to the 2000 review by the Institute of Medicine. Environ Health Perspect (2014) 1.13

Being overweight increases susceptibility to indoor pollutants among urban children with asthma. J Allergy Clin Immunol (2013) 1.00

Predicting Airborne Particle Levels Aboard Washington State School Buses. Atmos Environ (1994) (2008) 0.99

The use of alternative pollutant metrics in time-series studies of ambient air pollution and respiratory emergency department visits. J Expo Sci Environ Epidemiol (2009) 0.98

Effects of airborne particulate matter on respiratory morbidity in asthmatic children. J Epidemiol (2008) 0.95

Hospital admissions for asthma and acute bronchitis in El Paso, Texas: do age, sex, and insurance status modify the effects of dust and low wind events? Environ Res (2011) 0.95

The effects of PM2.5 and its components from indoor and outdoor sources on cough and wheeze symptoms in asthmatic children. J Expo Sci Environ Epidemiol (2014) 0.92

Gaseous air pollutants and hospitalization for respiratory disease in the neonatal period. Environ Health Perspect (2006) 0.91

Children's asthma hospitalizations and relative risk due to nitrogen dioxide (NO2): effect modification by race, ethnicity, and insurance status. Environ Res (2009) 0.90

The association of tree pollen concentration peaks and allergy medication sales in new york city: 2003-2008. ISRN Allergy (2011) 0.87

Ambient air pollution, lung function, and airway responsiveness in asthmatic children. J Allergy Clin Immunol (2015) 0.86

Air pollution and respiratory symptoms among children with asthma: vulnerability by corticosteroid use and residence area. Sci Total Environ (2012) 0.85

Associations between air pollution and peak expiratory flow among patients with persistent asthma. J Toxicol Environ Health A (2009) 0.80

Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo. Int J Nanomedicine (2015) 0.78

Ensemble-based source apportionment of fine particulate matter and emergency department visits for pediatric asthma. Am J Epidemiol (2015) 0.78

Fine-Scale Exposure to Allergenic Pollen in the Urban Environment: Evaluation of Land Use Regression Approach. Environ Health Perspect (2015) 0.77

Population intervention models to estimate ambient NO2 health effects in children with asthma. J Expo Sci Environ Epidemiol (2014) 0.77

Is there a Hispanic Health Paradox in Sensitivity to Air Pollution? Hospital Admissions for Asthma, Chronic Obstructive Pulmonary Disease and Congestive Heart Failure Associated with NO2 and PM2.5 in El Paso, TX, 2005-2010. Atmos Environ (1994) (2015) 0.76

New York City Panel on Climate Change 2015 Report. Chapter 5: Public health impacts and resiliency. Ann N Y Acad Sci (2015) 0.75

Associations of Cough Prevalence with Ambient Polycyclic Aromatic Hydrocarbons, Nitrogen and Sulphur Dioxide: A Longitudinal Study. Int J Environ Res Public Health (2016) 0.75

Hourly peak PM2.5 concentration associated with increased cardiovascular mortality in Guangzhou, China. J Expo Sci Environ Epidemiol (2016) 0.75

Particulate Air Pollution from Wildfires in the Western US under Climate Change. Clim Change (2016) 0.75

Articles cited by this

Increased mortality in Philadelphia associated with daily air pollution concentrations. Am Rev Respir Dis (1992) 6.09

The National Morbidity, Mortality, and Air Pollution Study. Part II: Morbidity and mortality from air pollution in the United States. Res Rep Health Eff Inst (2000) 5.64

Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects. Lancet (1991) 3.92

Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med (2001) 3.26

Fine particles are more strongly associated than coarse particles with acute respiratory health effects in schoolchildren. Epidemiology (2000) 3.13

The role of particulate pollutants in pulmonary inflammation and asthma: evidence for the involvement of organic chemicals and oxidative stress. Curr Opin Pulm Med (2001) 2.70

Evaluation of the TEOM method for measurement of ambient particulate mass in urban areas. J Air Waste Manag Assoc (1997) 2.53

Effects of particulate and gaseous air pollution on cardiorespiratory hospitalizations. Arch Environ Health (1999) 2.45

Urban air pollution and emergency admissions for asthma in four European cities: the APHEA Project. Thorax (1997) 2.31

Association of severe asthma attacks with weather, pollen, and air pollutants. Thorax (1993) 2.15

Late asthmatic responses. Am Rev Respir Dis (1987) 2.05

Air pollution and bronchitic symptoms in Southern California children with asthma. Environ Health Perspect (1999) 1.98

Air pollution and hospital admissions in Sydney, Australia, 1990 to 1994. Am J Public Health (1998) 1.98

Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients. Lancet (1995) 1.97

The effect of outdoor fungal spore concentrations on daily asthma severity. Environ Health Perspect (1997) 1.95

Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis (1987) 1.91

Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores. Am J Respir Crit Care Med (1996) 1.90

Total suspended particulate matter and daily mortality in Cincinnati, Ohio. Environ Health Perspect (1994) 1.86

Symptoms in pediatric asthmatics and air pollution: differences in effects by symptom severity, anti-inflammatory medication use and particulate averaging time. Environ Health Perspect (1998) 1.83

Air pollution and exacerbation of asthma in African-American children in Los Angeles. Epidemiology (2001) 1.81

Air pollution and acute respiratory illness in five German communities. Environ Res (1991) 1.74

Health effects of outdoor air pollution. Part 2. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society. Am J Respir Crit Care Med (1996) 1.68

Air pollution, pollens, and daily admissions for asthma in London 1987-92. Thorax (1998) 1.62

Effects of single- and multiday ozone exposures on respiratory function in active normal children. Environ Res (1991) 1.42

Inhalable particles and pulmonary host defense: in vivo and in vitro effects of ambient air and combustion particles. Environ Res (1985) 1.42

Medication use modifies the health effects of particulate sulfate air pollution in children with asthma. Environ Health Perspect (1997) 1.40

Air pollution and cause-specific mortality in Milan, Italy, 1980-1989. Arch Environ Health (1999) 1.40

Overview of issues in the longitudinal analysis of respiratory data. Am J Respir Crit Care Med (1996) 1.39

The effect of ozone on inner-city children with asthma: identification of susceptible subgroups. Am J Respir Crit Care Med (2000) 1.38

Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis (1991) 1.38

The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med (1999) 1.36

The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. Am J Respir Crit Care Med (1996) 1.33

Ozone exposure assessment in a southern California community. Environ Health Perspect (1997) 1.27

Greater ozone-induced inflammatory responses in subjects with asthma. Am J Respir Crit Care Med (1996) 1.26

The effect of exposure to ozone and nitrogen dioxide on the airway response of atopic asthmatics to inhaled allergen: dose- and time-dependent effects. Am J Respir Crit Care Med (1999) 1.22

Evaluation of a real-time passive personal particle monitor in fixed site residential indoor and ambient measurements. J Expo Anal Environ Epidemiol (2001) 1.19

Repeated exposure to an ambient level of NO2 enhances asthmatic response to a nonsymptomatic allergen dose. Eur Respir J (1998) 1.13

Air pollution, aeroallergens and cardiorespiratory emergency department visits in Saint John, Canada. J Expo Anal Environ Epidemiol (2001) 1.11

Nitrogen dioxide exposure enhances asthmatic reaction to inhaled allergen in subjects with asthma. Am J Respir Crit Care Med (1997) 1.06

Emergency room visits of asthmatic children, relation to air pollution, weather, and airborne allergens. Ann Allergy Asthma Immunol (1998) 1.03

Inhomogeneity in response to air pollution in European children (PEACE project). Occup Environ Med (1999) 1.03

Combined effects of aerobiological pollutants, chemical pollutants and meteorological conditions on asthma admissions and A & E attendances in Derbyshire UK, 1993-96. Clin Exp Allergy (2000) 1.03

Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. Am Rev Respir Dis (1991) 1.02

Persistent airway inflammation but accommodated antioxidant and lung function responses after repeated daily exposure to nitrogen dioxide. Am J Respir Crit Care Med (1999) 1.01

A synoptic evaluation of asthma hospital admissions in New York City. Am J Respir Crit Care Med (1997) 1.00

Personal exposure to nitrogen dioxide and risk of airflow obstruction in asthmatic children with upper respiratory infection. Thorax (2000) 0.99

Influenza virus infection in mice after exposure to coal dust and diesel engine emissions. Environ Res (1985) 0.93

Influence of ozone and nitrogen dioxide on histamine and interleukin formation in a human nasal mucosa culture system. Am J Respir Cell Mol Biol (1999) 0.92

Effects of ozone on normal and potentially sensitive human subjects. Part I: Airway inflammation and responsiveness to ozone in normal and asthmatic subjects. Res Rep Health Eff Inst (1997) 0.91

Exposure to nitrogen dioxide (NO2) and respiratory disease risk. Rev Environ Health (1998) 0.87

Exposure assessment approaches to evaluate respiratory health effects of particulate matter and nitrogen dioxide. J Expo Anal Environ Epidemiol (1991) 0.83

Articles by these authors

(truncated to the top 100)

Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med (2010) 6.51

Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med (2006) 6.10

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) (2008) 5.82

Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med (2005) 5.78

Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med (2008) 5.43

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet (2011) 5.42

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol (2005) 4.50

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol (2010) 3.54

Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med (2012) 3.51

Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol (2003) 2.93

Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol (2004) 2.80

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol (2006) 2.79

Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect (2005) 2.57

Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol (2008) 2.56

Association of FEV1 in asthmatic children with personal and microenvironmental exposure to airborne particulate matter. Environ Health Perspect (2004) 2.34

Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long-term results. Int J Radiat Oncol Biol Phys (2012) 2.09

The role of breast-feeding in the development of allergies and asthma. J Allergy Clin Immunol (2005) 2.05

The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest (2006) 1.93

Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J Allergy Clin Immunol (2005) 1.90

Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas. Cancer Prev Res (Phila) (2009) 1.86

Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing? J Allergy Clin Immunol (2013) 1.82

The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials (2004) 1.79

The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology (2008) 1.78

HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology (2010) 1.76

Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr (2009) 1.68

EUS compared with endoscopy plus transabdominal US in the initial diagnostic evaluation of patients with upper abdominal pain. Gastrointest Endosc (2010) 1.66

A regional comparison of mold spore concentrations outdoors and inside "clean" and "mold contaminated" Southern California buildings. J Occup Environ Hyg (2005) 1.55

Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol (2006) 1.54

Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol (2009) 1.51

Mild to moderate asthma affects lung growth in children and adolescents. J Allergy Clin Immunol (2006) 1.44

Telephone-based environmental control interventions in asthmatic patients: what are patients willing to do? Ann Allergy Asthma Immunol (2012) 1.40

Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging (2003) 1.40

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol (2009) 1.38

Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol (2008) 1.36

Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol (2008) 1.28

Genetic screening for iron overload: No evidence of discrimination at 1 year. J Fam Pract (2007) 1.27

Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol (2006) 1.26

Validity of the Asthma Control Test completed at home. Am J Manag Care (2007) 1.25

Dietary prevention of allergic diseases in infants and small children. Pediatr Allergy Immunol (2008) 1.24

Severe intermittent wheezing in preschool children: a distinct phenotype. J Allergy Clin Immunol (2007) 1.22

Healthcare provider and parent behavior and children's coping and distress at anesthesia induction. Anesthesiology (2009) 1.21

Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol (2009) 1.21

Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol (2008) 1.19

Effect of chorioamnionitis on early childhood asthma. Arch Pediatr Adolesc Med (2010) 1.17

Asthma-specific quality of life and subsequent asthma emergency hospital care. Am J Manag Care (2008) 1.16

The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial. Cancer Epidemiol Biomarkers Prev (2008) 1.15

Dietary prevention of allergic diseases in infants and small children. Part III: Critical review of published peer-reviewed observational and interventional studies and final recommendations. Pediatr Allergy Immunol (2004) 1.15

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol (2002) 1.15

Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma. Gastroenterology (2010) 1.14

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol (2012) 1.14

Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test (2005) 1.12

Serum ferritin and transferrin saturation in Asians and Pacific Islanders. Arch Intern Med (2007) 1.12

Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol (2011) 1.11

Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. J Allergy Clin Immunol (2006) 1.11

Pest and allergen exposure and abatement in inner-city asthma: a work group report of the American Academy of Allergy, Asthma & Immunology Indoor Allergy/Air Pollution Committee. J Allergy Clin Immunol (2010) 1.11

Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res (2013) 1.09

Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol (2007) 1.09

Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study. Clin Chem (2005) 1.09

Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene. PLoS Genet (2012) 1.09

Validation of the asthma impact survey, a brief asthma-specific quality of life tool. Qual Life Res (2006) 1.09

Test for respiratory and asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol (2009) 1.08

Improved asthma outcomes from allergy specialist care: a population-based cross-sectional analysis. J Allergy Clin Immunol (2005) 1.08

HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology (2009) 1.07

Dietary prevention of allergic diseases in infants and small children. Part II. Evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic diseases. Pediatr Allergy Immunol (2004) 1.06

Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol (2009) 1.06

The relationship between asthma-specific quality of life and asthma control. J Asthma (2007) 1.05

Predictors of remitting, periodic, and persistent childhood asthma. J Allergy Clin Immunol (2010) 1.05

The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. J Allergy Clin Immunol (2010) 1.05

Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin. Cancer Epidemiol Biomarkers Prev (2004) 1.03

Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma. J Allergy Clin Immunol (2010) 1.02

Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn Dis (2006) 1.02

Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort. Curr Respir Care Rep (2012) 1.01

Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol (2002) 1.01

Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial. J Allergy Clin Immunol (2011) 1.01

A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis. Br J Haematol (2009) 1.00

Predictors of poor response during asthma therapy differ with definition of outcome. Pharmacogenomics (2009) 0.99

Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol (2008) 0.98

Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population. Am J Hematol (2008) 0.98

Signs and symptoms that precede wheezing in children with a pattern of moderate-to-severe intermittent wheezing. J Pediatr (2009) 0.97

Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database. Am J Manag Care (2010) 0.97

Effect of elevated exhaled nitric oxide levels on the risk of respiratory tract illness in preschool-aged children with moderate-to-severe intermittent wheezing. Ann Allergy Asthma Immunol (2009) 0.96

Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. J Natl Cancer Inst (2010) 0.96

Age- and race-dependence of the fibroglandular breast density analyzed on 3D MRI. Med Phys (2010) 0.96

Power calculations for generalized linear models in observational longitudinal studies: a simulation approach in SAS. Comput Methods Programs Biomed (2006) 0.95

Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study. Can J Gastroenterol (2009) 0.95

Clinical significance of poor CD3 response in head and neck cancer. Clin Cancer Res (2002) 0.94

In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma. J Allergy Clin Immunol (2010) 0.93

Economic burden of impairment in children with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol (2011) 0.92

Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Blood Cells Mol Dis (2009) 0.92

Dietary prevention of allergic diseases in infants and small children. Part I: immunologic background and criteria for hypoallergenicity. Pediatr Allergy Immunol (2004) 0.91

Predictors of asthma control in a random sample of asthmatic patients. J Asthma (2007) 0.91

Integration of mouse and human genome-wide association data identifies KCNIP4 as an asthma gene. PLoS One (2013) 0.91

Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. J Allergy Clin Immunol (2014) 0.91

Improving asthma outcomes in large populations. J Allergy Clin Immunol (2011) 0.90

Development and validation of a medication intensity scale derived from computerized pharmacy data that predicts emergency hospital utilization for persistent asthma. Am J Manag Care (2006) 0.90

Determinants of future long-term asthma control. J Allergy Clin Immunol (2006) 0.90

Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. J Allergy Clin Immunol (2011) 0.90

HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Hepatology (2010) 0.89

Environmental assessment and exposure control: a practice parameter--furry animals. Ann Allergy Asthma Immunol (2012) 0.89

Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Hepatology (2012) 0.89